A Conversation About the FDA’s Regulation of Mifepristone
Release Date: 01/12/2026
Type 1 Diabetes: Diagnosis and Management
JAMA Clinical Reviews
Type 1 diabetes affects approximately 2 million people in the US and 8.4 million people worldwide. Author Desmond Schatz, MD, of the University of Florida joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence...
info_outline
Pharmaceutical Pricing: JAMA Talks With Mark Cuban
JAMA Clinical Reviews
Mark Cuban, entrepreneur, investor, and cofounder of the Mark Cuban Cost Plus Drug Company, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the role of pharmacy benefit managers, insurance formularies, and...
info_outline
Medications for Opioid Use Disorder, Withdrawal, and Overdose
JAMA Clinical Reviews
Opioid use disorder is the third most prevalent substance use disorder worldwide. Author Alexander Walley, MB, MSc, of Boston Medical Center and Boston University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the efficacy,...
info_outline
Ovarian Cancer Prevention With Opportunistic Fallopian Tube Removal
JAMA Clinical Reviews
Ovarian cancer may be prevented with removal of the fallopian tubes during pelvic or select abdominal surgery in eligible women. This procedure, opportunistic salpingectomy, can be offered to more eligible women. Author Jurgen M. Piek,...
info_outline
IgA Nephropathy in Adults
JAMA Clinical Reviews
IgA nephropathy is a chronic kidney disease involving deposition of IgA-containing immune complexes in the glomerulus, which often causes kidney failure within 10 to 20 years. Author Michelle Marie O'Shaughnessy, MB, BCh, BAO, MS, of...
info_outline
Restless Legs Syndrome
JAMA Clinical Reviews
Restless legs syndrome is a sleep-related neurologic disorder that causes an overwhelming urge to move the limbs, which can cause substantial sleep disturbance. Author John W. Winkelman, MD, PhD, of Harvard Medical School joins JAMA Deputy...
info_outline
A Conversation About the FDA’s Regulation of Mifepristone
JAMA Clinical Reviews
Mifepristone used with misoprostol is the most common abortion regimen in the US. It is also a focal point of reproductive health policy and politics, with controversy over its legal status and regulation by the US Food and Drug...
info_outline
Gastric Cancer Worldwide
JAMA Clinical Reviews
Incidence rates of gastric cancer in younger individuals are on the rise and gastric cancer is the fifth-leading cause of cancer-related deaths worldwide. JAMA Review author Haeseong Park, MD, MPH, from the Dana Farber Cancer Institute,...
info_outline
JAMA Editors' Choice 2025: Clinical Reviews Podcasts
JAMA Clinical Reviews
JAMA Deputy Editor Mary McDermott, MD, and JAMA Deputy Editor Kristin Walter, MD, MS, highlight their selections of top JAMA Clinical Reviews podcasts in 2025.
info_outline
From the JAMA Network: JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo
JAMA Clinical Reviews
In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal’s inaugural Research of the Year roundup. Related Content:
info_outlineMifepristone used with misoprostol is the most common abortion regimen in the US. It is also a focal point of reproductive health policy and politics, with controversy over its legal status and regulation by the US Food and Drug Administration (FDA). Author G. Caleb Alexander, MD, MS, from Johns Hopkins discusses this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS.
Related Content: